Stay updated on Dapagliflozin in Preserved EF Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin in Preserved EF Heart Failure Clinical Trial page.

Latest updates to the Dapagliflozin in Preserved EF Heart Failure Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page's revision tag updates from v3.5.3 to v3.5.4, indicating a newer build of the ClinicalTrials.gov history page. No study data or visible content is altered by this change.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA new revision entry v3.5.3 is added to the Record History, and the previous revision v3.5.2 is removed from the list.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. The change appears to modify only version metadata and does not alter study records or visible content.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 in the page footer.SummaryDifference0.1%

- Check72 days agoChange DetectedThe history now shows Revision: v3.4.3. The previous Revision: v3.4.2 entry was removed.SummaryDifference0.1%

- Check101 days agoChange DetectedRevision history shows a new Revision: v3.4.2 added and the operating-status funding notice removed.SummaryDifference0.5%

Stay in the know with updates to Dapagliflozin in Preserved EF Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin in Preserved EF Heart Failure Clinical Trial page.